R

Rigontec

Acquired
Business Model
B2B

About

Rigontec pioneered therapeutics targeting the RIG-I receptor in immuno-oncology before Merck acquired the company in 2017.

Summary

Rigontec is a Biotech company.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rigontec on Indexed.vc
<a href="https://indexed.vc/companies/rigontec"><img src="https://indexed.vc/api/badge/company/rigontec" alt="Rigontec on Indexed.vc" width="260" height="76" /></a>